Annual EBITDA
-$195.85 M
-$25.10 M-14.70%
December 31, 2024
Summary
- As of March 3, 2025, PRME annual EBITDA is -$195.85 million, with the most recent change of -$25.10 million (-14.70%) on December 31, 2024.
- During the last 3 years, PRME annual EBITDA has fallen by -$112.34 million (-134.51%).
- PRME annual EBITDA is now -1565.99% below its all-time high of -$11.76 million, reached on December 31, 2020.
Performance
PRME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$42.56 M
+$10.32 M+19.52%
December 31, 2024
Summary
- As of March 3, 2025, PRME quarterly EBITDA is -$42.56 million, with the most recent change of +$10.32 million (+19.52%) on December 31, 2024.
- Over the past year, PRME quarterly EBITDA has increased by +$5.63 million (+11.68%).
- PRME quarterly EBITDA is now -1585.70% below its all-time high of -$2.52 million, reached on December 31, 2019.
Performance
PRME Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$195.85 M
-$2.13 M-1.10%
December 31, 2024
Summary
- As of March 3, 2025, PRME TTM EBITDA is -$195.85 million, with the most recent change of -$2.13 million (-1.10%) on December 31, 2024.
- Over the past year, PRME TTM EBITDA has dropped by -$107.23 million (-121.00%).
- PRME TTM EBITDA is now -7656.59% below its all-time high of -$2.52 million, reached on December 31, 2019.
Performance
PRME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PRME EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.7% | +11.7% | -121.0% |
| 3 y3 years | -134.5% | +11.7% | -121.0% |
| 5 y5 years | -1566.0% | +11.7% | -121.0% |
PRME EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -134.5% | at low | -181.5% | +30.6% | -384.4% | at low |
| 5 y | 5-year | -1566.0% | at low | -1585.7% | +30.6% | -7656.6% | at low |
| alltime | all time | -1566.0% | at low | -1585.7% | +30.6% | -7656.6% | at low |
Prime Medicine EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$195.85 M(+14.7%) | -$42.56 M(-19.5%) | -$195.85 M(+1.1%) |
| Sep 2024 | - | -$52.89 M(+1.3%) | -$193.72 M(+37.6%) |
| Jun 2024 | - | -$52.21 M(+8.3%) | -$140.83 M(+58.9%) |
| Mar 2024 | - | -$48.19 M(+19.2%) | -$88.62 M(+119.2%) |
| Dec 2023 | -$170.76 M(+60.8%) | -$40.43 M(+23.2%) | -$40.43 M(-69.2%) |
| Dec 2022 | -$106.19 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$32.81 M(+48.1%) | -$131.39 M(+33.3%) |
| Jun 2022 | - | -$22.15 M(+46.5%) | -$98.57 M(+29.0%) |
| Mar 2022 | - | -$15.12 M(-75.3%) | -$76.42 M(+24.7%) |
| Dec 2021 | -$83.52 M(+610.4%) | -$61.30 M(+2327.8%) | -$61.30 M(+2327.8%) |
| Dec 2020 | -$11.76 M | - | - |
| Dec 2019 | - | -$2.52 M | -$2.52 M |
FAQ
- What is Prime Medicine annual EBITDA?
- What is the all time high annual EBITDA for Prime Medicine?
- What is Prime Medicine annual EBITDA year-on-year change?
- What is Prime Medicine quarterly EBITDA?
- What is the all time high quarterly EBITDA for Prime Medicine?
- What is Prime Medicine quarterly EBITDA year-on-year change?
- What is Prime Medicine TTM EBITDA?
- What is the all time high TTM EBITDA for Prime Medicine?
- What is Prime Medicine TTM EBITDA year-on-year change?
What is Prime Medicine annual EBITDA?
The current annual EBITDA of PRME is -$195.85 M
What is the all time high annual EBITDA for Prime Medicine?
Prime Medicine all-time high annual EBITDA is -$11.76 M
What is Prime Medicine annual EBITDA year-on-year change?
Over the past year, PRME annual EBITDA has changed by -$25.10 M (-14.70%)
What is Prime Medicine quarterly EBITDA?
The current quarterly EBITDA of PRME is -$42.56 M
What is the all time high quarterly EBITDA for Prime Medicine?
Prime Medicine all-time high quarterly EBITDA is -$2.52 M
What is Prime Medicine quarterly EBITDA year-on-year change?
Over the past year, PRME quarterly EBITDA has changed by +$5.63 M (+11.68%)
What is Prime Medicine TTM EBITDA?
The current TTM EBITDA of PRME is -$195.85 M
What is the all time high TTM EBITDA for Prime Medicine?
Prime Medicine all-time high TTM EBITDA is -$2.52 M
What is Prime Medicine TTM EBITDA year-on-year change?
Over the past year, PRME TTM EBITDA has changed by -$107.23 M (-121.00%)